Biomarker Landscape in Cancer Research examines the impact of early detection, predication of aggressiveness, and the determination of the best treatment for cancers. With a strong focus on the status, challenges, and prospects of biomarker measurements' tools and technology, the book also examines clinical translation-related knowledge and the prognosis of different organ related cancers. In 21 chapters, it describes current and new diagnostic tools in twenty different cancers and explores how innovations in the cancer diagnostic space could make cancer screening and early detection more straightforward.
This book is a timely and valuable resource for health professionals, scientists and researchers, health practitioners, students, and all those who wish to broaden their knowledge in the allied field.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Contributors - p. vii 7. About the editors - p. xiii 8. Preface - p. xv 9. 1. Liver cancer: Biomarker landscape - p. 1 10. 2. Pancreatic cancer: Biomarker landscape - p. 25 11. 3. Heart cancer: Biomarker landscape - p. 41 12. 4. Bone cancer: Biomarker landscape - p. 75 13. 5. Spleen cancer: Biomarkers landscape - p. 111 14. 6. Brain–CNS cancer: Biomarker landscape - p. 143 15. 7. Skin cancer: Biomarker landscape - p. 189 16. 8. Lung cancer: Biomarker landscape - p. 231 17. 9. Thyroid cancer: Biomarker landscape - p. 269 18. 10. Breast cancer: Biomarker landscape - p. 291 19. 11. Breast cancer: Role of microRNAs as biomarker - p. 321 20. 12. Colorectal cancer: Biomarker landscape - p. 343 21. 13. Blood cancer: Biomarker landscape - p. 373 22. 14. Prostate cancer: Biomarker landscape - p. 403 23. 15. Ovarian cancer: Biomarker landscape - p. 423 24. 16. Oral cancer: Biomarker landscape - p. 457 25. 17. Ocular cancer: Biomarker landscape - p. 485 26. Index - p. 503
Biomarker Landscape in Cancer Research examines the impact of early detection, predication of aggressiveness, and the determination of the best treatment for cancers. With a strong focus on the status, challenges, and prospects of biomarker measurements' tools and technology, the book also examines clinical translation-related knowledge and the prognosis of different organ related cancers. In 21 chapters, it describes current and new diagnostic tools in twenty different cancers and explores how innovations in the cancer diagnostic space could make cancer screening and early detection more straightforward.
This book is a timely and valuable resource for health professionals, scientists and researchers, health practitioners, students, and all those who wish to broaden their knowledge in the allied field.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Contributors - p. vii 7. About the editors - p. xiii 8. Preface - p. xv 9. 1. Liver cancer: Biomarker landscape - p. 1 10. 2. Pancreatic cancer: Biomarker landscape - p. 25 11. 3. Heart cancer: Biomarker landscape - p. 41 12. 4. Bone cancer: Biomarker landscape - p. 75 13. 5. Spleen cancer: Biomarkers landscape - p. 111 14. 6. Brain–CNS cancer: Biomarker landscape - p. 143 15. 7. Skin cancer: Biomarker landscape - p. 189 16. 8. Lung cancer: Biomarker landscape - p. 231 17. 9. Thyroid cancer: Biomarker landscape - p. 269 18. 10. Breast cancer: Biomarker landscape - p. 291 19. 11. Breast cancer: Role of microRNAs as biomarker - p. 321 20. 12. Colorectal cancer: Biomarker landscape - p. 343 21. 13. Blood cancer: Biomarker landscape - p. 373 22. 14. Prostate cancer: Biomarker landscape - p. 403 23. 15. Ovarian cancer: Biomarker landscape - p. 423 24. 16. Oral cancer: Biomarker landscape - p. 457 25. 17. Ocular cancer: Biomarker landscape - p. 485 26. Index - p. 503
